Bristol-based new biotech company is developing ground-breaking treatments for Covid-19
Apr 16 2021
A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented
potential treatments for Coronavirus.
Bristol-based Halo Therapeutics is founded by the team of leading scientists who made a recent breakthrough discovery, which was published in Science Magazine. They found that exposing the SARS-CoV-2 (Coronavirus) virus to a free fatty acid called linoleic acid locks the virus’s spike protein into a closed, non-infective form stopping it in its tracks.
The company is now preparing to make an application to start clinical trials with infected patients . If proven to be effective, the antivirals could be used by people of all ages world wide at the first sign of Covid-19 symptoms, or if they have been in contact with someone with the virus, preventing the virus from taking hold and